The agreement marks a departure from traditional trade pacts that prioritize simple market access. With 125 cooperation provisions, it emphasizes regulatory dialogue over mere duty elimination. In sectors like pharmaceuticals, where India remains a global leader in generics, the real barrier to the EU market is not tariffs but complex compliance and pharmacovigilance systems. The deal forces both parties to harmonize standards, shifting the burden from customs desks to institutional regulators.
This shift is equally visible in the climate sphere. By creating a carbon border annex rather than seeking an exemption from the EU’s Carbon Border Adjustment Mechanism (CBAM), India has transitioned from confrontation to technical engagement. This framework offers a path for industrial decarbonization, provided the EU delivers promised financial and technical support. Success now hinges on whether this institutional architecture can withstand the pressures of domestic reform and competing bureaucratic priorities in both Brussels and New Delhi.
Ultimately, the agreement acts as a stabilizer for a broader economic network stretching across the Indian Ocean. While physical connectivity projects like IMEC build the logistics of trade, this FTA provides the necessary rules of engagement. Whether this partnership becomes a pillar of global trade or remains a hollow text depends entirely on post-signature implementation. Trust, in this context, is not a legal guarantee but a product of sustained, friction-reducing cooperation that must be proven in practice.
Comments (0)
No comments yet. Be the first!